Anavex amends bylaws to require independent Board Chair, CEO cannot hold the role

ANAVEX LIFE SCIENCES CORP.

Board of Directors adopted amended bylaws on April 11, 2023, effective immediately.
Chairman of the Board must be an independent director and cannot be held by the CEO.
Amended and Restated Bylaws filed as Exhibit 3.1 to the 8-K.
Previous bylaws allowed CEO to serve as Chairman; separation enhances governance.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ANAVEX LIFE SCIENCES CORP.: Amended Bylaws to require Chairman of the Board to be an independent director and prohibit CEO from holding that position (effective 2023-04-11).

Change: bylaw amendment
Effective: 2023-04-11

Exact text from the filing

The Board amended the Company’s Bylaws to require that the position of Chairman of the Board of Directors must be filled by an independent director and cannot be held by the Chief Executive Officer of the Company.

View on SEC.gov

Browse all governance changes →

ANAVEX LIFE SCIENCES CORP. filing history →

Source: SEC EDGAR

accession 0001731122-23-000651

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.